[ad_1]
Novavax Inc mentioned on Wednesday it had filed an utility with
Britain’s medicine regulator for the authorization of its COVID-19
vaccine amongst adolescents aged 12 and older, Development reviews citing Reuters.
Britain had in February cleared the two-dose vaccine, Nuvaxovid,
to be used in adults amid a spike in circumstances fueled by the Omicron
variant of the coronavirus.
Novavax’s submission consists of information from a late-stage trial in
america, the place the vaccine confirmed 80% efficacy amongst
adolescents when Delta was the dominant variant within the nation.
The drugmaker in late January filed for emergency use
authorization of its COVID-19 shot for adults within the United
States.
[ad_2]
Source link